Therapeutic concentrations of theophylline and enprofylline potentiate catecholamine effects and inhibit leukocyte activation
- 1 October 1986
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 78 (4) , 660-667
- https://doi.org/10.1016/0091-6749(86)90086-2
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Adenosine: a physiological modulator of superoxide anion generation by human neutrophils.The Journal of Experimental Medicine, 1983
- Intravenous administration of enprofylline to asthmatic patientsEuropean Journal of Clinical Pharmacology, 1983
- Xanthine derivatives as adenosine receptor antagonistsEuropean Journal of Pharmacology, 1982
- Association of neutrophil chemiluminescence with microbicidal activityClinical Immunology and Immunopathology, 1982
- Compartmentalization of Cyclic AMP During Phagocytosis by Human Neutrophilic GranulocytesScience, 1981
- Apparent irrelevance of cyclic nucleotides to the relaxation of tracheal smooth muscle induced by theophyllineLung, 1979
- INHIBITION OF HUMAN PULMONARY PHOSPHODIESTERASE ACTIVITY BY THERAPEUTIC LEVELS OF THEOPHYLLINEClinical and Experimental Pharmacology and Physiology, 1978
- Effect of anti-inflammatory drugs and agents that elevate intracellular cyclic AMP on the release of toxic oxygen metabolites by phagocytes: Studies in a model of tissue-bound IgGClinical Immunology and Immunopathology, 1978
- Stimulation of the oxidative metabolism of polymorphonuclear leucocytes by the calcium ionophore A23187FEBS Letters, 1974
- Synthesis and biological activity of some 2' derivatives of adenosine 3',5'-cyclic phosphateBiochemistry, 1973